Last reviewed · How we verify
NCT07199270
A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy Adult
Phase 1 trial testing GR2303 injection in Health Adult Subjects in 64 participants. Currently enrolling.
18 September 2026
Quick facts
| Lead sponsor | Genrix (Shanghai) Biopharmaceutical Co., Ltd. |
|---|---|
| Phase | Phase 1 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 18 September 2025 |
| Primary completion | 18 September 2026 |
| Estimated completion | 16 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- GR2303 injection — full drug profile →
- Placebo
- GR2303 injection — full drug profile →
- Placebo
Conditions studied
- Health Adult Subjects — all drugs for Health Adult Subjects →
Sponsor
Genrix (Shanghai) Biopharmaceutical Co., Ltd. — full company profile →
Who can join
Adults 18 to 45, any sex, with Health Adult Subjects. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
he goal this clinical trail is to evaluate the safety、Pharmacokinetic and immunogenicity of GR2303 injection。 Subjects will be enrolled in different groups in sequential order, and within each group will be randomly assigned to receive either GR2303 injection or placebo administration, with each Subjects will be enrolled in only one of these groups
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07199270
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Health Adult Subjects
Currently open trials in the same condition.
- NCT07534657 — A Study of JPH034 in Healthy Adult Participants · Phase 1 · recruiting
- NCT07468981 — Movement Quality and Mechanical Properties of the Muscle · active not recruiting
- NCT07433829 — Prefrontal Neuroplasticity and Coping Strategies in Healthy Population · NA · recruiting
- NCT07465848 — Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis · NA · recruiting
- NCT07178288 — Assessment of Pressure Pain Threshold (PPT) and Conditioned Pain Modulation (CPM) After Effect in Patients With and With · NA · recruiting
Other Genrix (Shanghai) Biopharmaceutical Co., Ltd. trials
Trials by the same sponsor.
- NCT07348055 — A Study of GR1803 in Systemic Lupus Erythematosus · Phase 1, PHASE2 · recruiting
- NCT07190716 — A Study to Evaluate the Safety of GR2301 Injection in Healthy Volunteers. · Phase 1 · not yet recruiting
- NCT07199257 — A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis. · Phase 3 · not yet recruiting
- NCT07090954 — A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Mul · Phase 1, PHASE2 · not yet recruiting
- NCT07154342 — A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07199270 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Last refreshed: 30 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07199270.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing